查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750631

全球細胞和基因治療生物分析測試服務市場規模、佔有率、趨勢分析報告：按測試類型、開發階段、產品類型、適應症、地區和細分市場預測（2025-2030 年）

Cell And Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Stage Of Development, By Product Type, By Indication, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 261 Pages | 商品交期: 2-10個工作天內

價格

細胞和基因治療生物分析測試服務市場成長和趨勢：

根據Grand View Research, Inc.的最新報告，全球細胞和基因治療生物分析測試服務市場規模預計到2030年將達到8.287億美元，2025年至2030年期間的複合年成長率為7.40%。

細胞和基因治療相關研發活動的增加、公共組織對細胞和基因治療研究的投資增加以及基因和細胞治療在治療罕見疾病方面的巨大潛力是推動市場成長的主要因素。

細胞和基因療法已被廣泛應用於治療癌症、自體免疫疾病和罕見疾病。這些治療方法已被證明能夠顯著改善患者的臨床狀況，從而催生了大量細胞和基因療法候選藥物。例如，根據美國細胞和基因治療學會的數據，截至2023年1月，已有超過2,053種基因治療藥物和827種非基因改造細胞治療藥物正在研發中。大量的細胞和基因治療候選藥物正在推動對生物分析測試服務的需求。

公共和私營部門正在積極投資基於細胞和基因治療的研究。例如，2023年4月，加州再生醫學研究所投資8,900萬美元用於幹細胞和基因治療研究。這筆資金計畫用於開發持續性角膜上皮缺損的治療方法。預計未來類似的資金籌措將在預測期內提振對生物分析檢測服務的需求。

新冠疫情對細胞和基因治療生物分析檢測服務市場產生了負面影響。疫情導致大多數基於細胞和基因治療的臨床試驗被推遲。然而，在後疫情時代，情況正在發生變化，許多測試正在恢復。預計這將支持後疫情時代的市場成長。

細胞和基因治療生物分析測試服務市場報告重點

  • 預計生物有效性和生物等效性測試將在 2024 年佔據 35.44% 的市場佔有率，並有望在預測期內以最快的速度成長。
  • 2024 年，非臨床測試佔據了市場主導地位。開發階段部分根據產品類型進一步細分，包括基因治療、基因改造細胞治療和細胞治療。
  • 從產品角度來看，細胞療法將在2024年佔據市場主導地位。細胞療法是指移植人體細胞來修復或取代受損的組織或細胞。預計在預測期內，基因改造細胞療法領域將實現最快的成長。
  • 腫瘤學領域佔據了市場主導地位，佔據了 2024 年最大的收益佔有率。預計罕見疾病領域在預測期內將實現最快的複合年成長率。
  • 北美將主導細胞和基因治療生物分析測試服務市場，佔據 2024 年 41.57% 的最大收益佔有率。預計亞太地區細胞和基因治療生物分析測試服務在預測期內將實現最快的複合年成長率。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 細胞和基因治療生物分析測試服務市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗量分析（2024年）
    • 各地區臨床試驗總數
    • 各階段臨床試驗總數
    • 按研究設計分類的臨床試驗總數
    • 按主要治療領域分類的臨床試驗總量
  • 定價模式分析
  • 技術格局
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章細胞和基因治療生物分析測試服務市場：測試類型估計和趨勢分析

  • 細胞和基因治療生物分析測試服務市場（按測試類型：細分儀表板）
  • 細胞和基因治療生物分析測試服務市場（按測試類型：變異分析）
  • 按測試類型，2018-2030
  • 生物有效性和生物等效性測試
  • 藥物動力學
  • 動態
  • 其他

第5章細胞和基因治療生物分析測試服務市場：產品類型估計和趨勢分析

  • 細胞和基因治療生物分析測試服務市場（按產品類型：細分儀表板）
  • 細胞和基因治療生物分析測試服務市場（按產品類型）：變異分析
  • 依產品類型，2018-2030
  • 基因治療
    • 體外
    • 體內
  • 基因改造細胞療法
    • CAR-T細胞療法
    • CAR-NK細胞療法
    • TCR-T細胞療法
    • 其他
  • 細胞療法

第6章細胞和基因治療生物分析測試服務市場：發展階段評估和趨勢分析

  • 細胞和基因治療生物分析測試服務市場（按發展階段：細分儀表板）
  • 細胞和基因治療生物分析檢測服務市場（按發展階段：波動分析）
  • 依發展階段分類，2018-2030 年
  • 非臨床
    • 基因治療
    • 基因改造細胞療法
    • 細胞療法
  • 臨床
    • 基因治療
    • 基因改造細胞療法
    • 細胞療法

第7章細胞和基因治療生物分析測試服務市場：適應症估計和趨勢分析

  • 細胞和基因治療生物分析測試服務市場（按適應症：細分儀表板）
  • 細胞和基因治療生物分析檢測服務市場（按適應症：變異分析）
  • 依適應症，2018-2030年
  • 瘤
  • 感染疾病
  • 神經系統疾病
  • 罕見疾病
  • 其他

8. 細胞和基因治療生物分析測試服務市場：區域估計和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • BioAgilytix Labs
    • KCAS Bioanalytical Services
    • IQVIA, Inc.
    • Laboratory Corporation of America Holdings
    • Pharmaceutical Product Development, Inc.（Thermo Fisher Scientific Inc.）
    • Prolytix
    • Pharmaron
    • Charles River Laboratories
    • Syneos Health
    • SGS SA
    • Intertek Group Plc
Product Code: GVR-4-68040-078-3

Cell And Gene Therapy Bioanalytical Testing Services Market Growth & Trends:

The global cell and gene therapy bioanalytical testing services market size is expected to reach USD 828.7 million by 2030, registering a CAGR of 7.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing R&D activities related to cell and gene therapy, growth in investments by public organizations for cell and gene therapy research and high potential of gene and cell therapy in treating rare diseases are the key factors driving the growth of the market.

Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.

Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.

The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.

Cell And Gene Therapy Bioanalytical Testing Services Market Report Highlights:

  • The bioavailability & bioequivalence studies dominated with a market share of 35.44% in 2024 and are also expected to witness the fastest growth over the forecast period.
  • The non-clinical segment dominated the market in 2024. The stage of development segment has been further classified based on the product type, which includes gene therapy, gene-modified cell therapy, and cell therapy.
  • The cell therapy segment dominated the product segment in 2024. Cell therapy is the transplantation of human cells to repair or replace damaged tissue or cells. The gene-modified cell therapy segment is expected to register the fastest growth during the forecast period.
  • The oncology segment dominated the market and accounted for the largest revenue share in 2024. The rare diseases segment is expected to register the fastest CAGR during the forecast period.
  • North America dominated the cell and gene therapy bioanalytical testing services market and accounted for the largest revenue share of 41.57% in 2024. Asia Pacific cell and gene therapy bioanalytical testing services are anticipated to witness the fastest CAGR over the forecast period.

Table of Content

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cell & Gene Therapy Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Significant Number of Cell & Gene Therapy Drug Candidates Under Clinical Trials
      • 3.2.1.2. High Public and Private Investments Across Research and Development for Novel Cell & Gene Products
      • 3.2.1.3. High Focus of Biopharmaceutical Companies to Reduce Operational Costs Promoting the Demand for Outsourcing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of Alternative Treatment Options at Lower Cost
      • 3.2.2.2. Quality Issues Associated With Outsourcing
  • 3.3. Clinical Trials Volume Analysis (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 4.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Segment Dashboard
  • 4.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Movement Analysis
  • 4.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million)
  • 4.4. Bioavailability & Bioequivalence Studies
    • 4.4.1. Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pharmacokinetics
    • 4.5.1. Pharmacokinetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Pharmacodynamics
    • 4.6.1. Pharmacodynamics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Estimates & Trend Analysis

  • 5.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Segment Dashboard
  • 5.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Movement Analysis
  • 5.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Product Type, 2018 - 2030 (USD Million)
  • 5.4. Gene Therapy
    • 5.4.1. Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Ex-vivo
      • 5.4.2.1. Ex-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. In-vivo
      • 5.4.3.1. In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gene-Modified Cell Therapy
    • 5.5.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. CAR T-cell therapies
      • 5.5.2.1. CAR T-cell therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. CAR-NK cell therapy
      • 5.5.3.1. CAR-NK cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. TCR-T cell therapy
      • 5.5.4.1. TCR-T cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Other
      • 5.5.5.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cell Therapy
    • 5.6.1. Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type, Estimates & Trend Analysis

  • 6.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Segment Dashboard
  • 6.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Movement Analysis
  • 6.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • 6.4. Non-Clinical
    • 6.4.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Gene Therapy
      • 6.4.2.1. Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Gene-Modified Cell Therapy
      • 6.4.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Cell Therapy
      • 6.4.4.1. Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Clinical
    • 6.5.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Gene Therapy
      • 6.5.2.1. Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Gene-Modified Cell Therapy
      • 6.5.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Cell Therapy
      • 6.5.4.1. Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Estimates & Trend Analysis

  • 7.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Segment Dashboard
  • 7.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Movement Analysis
  • 7.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Indication, 2018 - 2030 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Neurological disorders
    • 7.6.1. Neurological disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Rare Diseases
    • 7.7.1. Rare Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Cell & Gene Therapy Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. BioAgilytix Labs
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. KCAS Bioanalytical Services
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. IQVIA, Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Laboratory Corporation of America Holdings
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Prolytix
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Pharmaron
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Charles River Laboratories
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Syneos Health
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. SGS SA
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Intertek Group Plc
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 6. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 7. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 10. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 11. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 12. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 14. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 15. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 16. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 17. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 18. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 19. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 20. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 21. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 22. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 23. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 24. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 25. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 27. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 28. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 29. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 30. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 31. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 32. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 33. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 34. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 35. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 36. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 37. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 38. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 39. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 40. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 41. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 42. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 43. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 44. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 45. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 46. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 47. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 48. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 49. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 50. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 51. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 52. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 53. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 54. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 55. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 56. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 57. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 58. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 59. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 60. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 61. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 67. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 68. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 69. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 70. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 71. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 72. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 73. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 74. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 75. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 76. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 77. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 78. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 79. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 80. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 81. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 82. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 83. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 84. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 85. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 86. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 87. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 88. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 89. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 90. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 91. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 93. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 94. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 95. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 96. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 97. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 98. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 99. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 100. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 101. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 102. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 103. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 109. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 110. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 111. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 112. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 117. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 118. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 119. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 120. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type outlook and key takeaways
  • Fig. 20 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type movement analysis
  • Fig. 21 Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pharmacokinetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacodynamics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other Test Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type outlook and key takeaways
  • Fig. 26 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type movement analysis
  • Fig. 27 Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Ex-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 CAR T-cell therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 CAR-NK cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 TCR-T cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type outlook and key takeaways
  • Fig. 37 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type movement analysis
  • Fig. 38 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication outlook and key takeaways
  • Fig. 47 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication movement analysis
  • Fig. 48 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Neurological disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Rare Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Regional Marketplace: Key Takeaways
  • Fig. 54 North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 MEA Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key company categorization
  • Fig. 106 Service heat map analysis
  • Fig. 107 Strategic framework